127 related articles for article (PubMed ID: 37529875)
1. MEX3A induces the development of thyroid cancer via targeting CREB1.
Feng G; Wang P; Zhang H; Cheng S; Xing Y; Wang Y
Cell Biol Int; 2023 Nov; 47(11):1843-1853. PubMed ID: 37529875
[TBL] [Abstract][Full Text] [Related]
2. MEX3A promotes development and progression of breast cancer through regulation of PIK3CA.
Shi X; Sun Y; Zhang Y; Wang W; Xu J; Guan Y; Ding Y; Yao Y
Exp Cell Res; 2021 Jul; 404(1):112580. PubMed ID: 33811903
[TBL] [Abstract][Full Text] [Related]
3. MEX3A is upregulated in esophageal squamous cell carcinoma (ESCC) and promotes development and progression of ESCC through targeting CDK6.
Wei L; Wang B; Hu L; Xu Y; Li Z; Shen Y; Huang H
Aging (Albany NY); 2020 Nov; 12(21):21091-21113. PubMed ID: 33188661
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-139-5p Suppresses Cell Malignant Behaviors in Breast Cancer through Targeting MEX3A.
Chu J; Li T; Li L; Fan H
Comput Math Methods Med; 2021; 2021():6591541. PubMed ID: 34765013
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive Analysis of Prognostic Value of MEX3A and Its Relationship with Immune Infiltrates in Ovarian Cancer.
Zhang P; Su T; Zhang S
J Immunol Res; 2021; 2021():5574176. PubMed ID: 34189143
[TBL] [Abstract][Full Text] [Related]
6. MEX3A Mediates p53 Degradation to Suppress Ferroptosis and Facilitate Ovarian Cancer Tumorigenesis.
Wang CK; Chen TJ; Tan GYT; Chang FP; Sridharan S; Yu CA; Chang YH; Chen YJ; Cheng LT; Hwang-Verslues WW
Cancer Res; 2023 Jan; 83(2):251-263. PubMed ID: 36354374
[TBL] [Abstract][Full Text] [Related]
7. Mex-3 RNA binding MEX3A promotes the proliferation and migration of breast cancer cells via regulating RhoA/ROCK1/LIMK1 signaling pathway.
Yan L; Li H; An W; Wei W; Zhang X; Wang L
Bioengineered; 2021 Dec; 12(1):5850-5858. PubMed ID: 34486491
[TBL] [Abstract][Full Text] [Related]
8. SMYD2 epigenetically activates MEX3A and suppresses CDX2 in colorectal cancer cells to augment cancer growth.
Pan L; Fan Y; Zhou L
Clin Exp Pharmacol Physiol; 2022 Sep; 49(9):959-969. PubMed ID: 35637161
[TBL] [Abstract][Full Text] [Related]
9. MEX3A promotes the malignant progression of ovarian cancer by regulating intron retention in TIMELESS.
Li F; Zhao C; Diao Y; Wang Z; Peng J; Yang N; Qiu C; Kong B; Li Y
Cell Death Dis; 2022 Jun; 13(6):553. PubMed ID: 35715407
[TBL] [Abstract][Full Text] [Related]
10. Mex3a interacts with LAMA2 to promote lung adenocarcinoma metastasis via PI3K/AKT pathway.
Liang J; Li H; Han J; Jiang J; Wang J; Li Y; Feng Z; Zhao R; Sun Z; Lv B; Tian H
Cell Death Dis; 2020 Aug; 11(8):614. PubMed ID: 32792503
[TBL] [Abstract][Full Text] [Related]
11. MEX3A promotes triple negative breast cancer proliferation and migration via the PI3K/AKT signaling pathway.
Jiang S; Meng L; Chen X; Liu H; Zhang J; Chen F; Zheng J; Liu H; Wang F; Hu J; Li Z
Exp Cell Res; 2020 Oct; 395(2):112191. PubMed ID: 32738346
[TBL] [Abstract][Full Text] [Related]
12. MEX3A contributes to development and progression of glioma through regulating cell proliferation and cell migration and targeting CCL2.
Yang C; Zhan H; Zhao Y; Wu Y; Li L; Wang H
Cell Death Dis; 2021 Jan; 12(1):14. PubMed ID: 33414423
[TBL] [Abstract][Full Text] [Related]
13. CREB1/Lin28/miR-638/VASP Interactive Network Drives the Development of Breast Cancer.
Hu PC; Li K; Tian YH; Pan WT; Wang Y; Xu XL; He YQ; Gao Y; Wei L; Zhang JW
Int J Biol Sci; 2019; 15(12):2733-2749. PubMed ID: 31754343
[TBL] [Abstract][Full Text] [Related]
14. MEX3A promotes angiogenesis in colorectal cancer via glycolysis.
Lu Y; Bi T; Zhou S; Guo M
Libyan J Med; 2023 Dec; 18(1):2202446. PubMed ID: 37155144
[TBL] [Abstract][Full Text] [Related]
15. RNA-Binding Protein MEX3A Interacting with DVL3 Stabilizes Wnt/β-Catenin Signaling in Endometrial Carcinoma.
Yang P; Zhang P; Zhang S
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614043
[TBL] [Abstract][Full Text] [Related]
16. The RNA-binding protein MEX3A is a prognostic factor and regulator of resistance to gemcitabine in pancreatic ductal adenocarcinoma.
Panzeri V; Manni I; Capone A; Naro C; Sacconi A; Di Agostino S; de Latouliere L; Montori A; Pilozzi E; Piaggio G; Capurso G; Sette C
Mol Oncol; 2021 Feb; 15(2):579-595. PubMed ID: 33159833
[TBL] [Abstract][Full Text] [Related]
17. MEX3A promotes nasopharyngeal carcinoma progression via the miR-3163/SCIN axis by regulating NF-κB signaling pathway.
Xiang XX; Liu YL; Kang YF; Lu X; Xu K
Cell Death Dis; 2022 Apr; 13(4):420. PubMed ID: 35490173
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-433 inhibits liver cancer cell migration by repressing the protein expression and function of cAMP response element-binding protein.
Yang Z; Tsuchiya H; Zhang Y; Hartnett ME; Wang L
J Biol Chem; 2013 Oct; 288(40):28893-9. PubMed ID: 23979134
[TBL] [Abstract][Full Text] [Related]
19. Identification of sumoylation sites in CCDC6, the first identified RET partner gene in papillary thyroid carcinoma, uncovers a mode of regulating CCDC6 function on CREB1 transcriptional activity.
Luise C; Merolla F; Leone V; Paladino S; Sarnataro D; Fusco A; Celetti A
PLoS One; 2012; 7(11):e49298. PubMed ID: 23145146
[TBL] [Abstract][Full Text] [Related]
20. Oncogenic cAMP responsive element binding protein 1 is overexpressed upon loss of tumor suppressive miR-10b-5p and miR-363-3p in renal cancer.
Li Y; Chen D; Li Y; Jin L; Liu J; Su Z; Qi Z; Shi M; Jiang Z; Ni L; Yang S; Gui Y; Mao X; Chen Y; Lai Y
Oncol Rep; 2016 Apr; 35(4):1967-78. PubMed ID: 26796749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
